Author:
van den Besselaar Antonius M. H. P.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Bain B., Forster T., Sleigh B.: Heparin and the activated partial thromboplastin time. A difference betweenin-vitro andin-vivo effects and implications for the therapeutic range — Amer. J. Clin. Pathol.74, 668, 1980.
2. Barrowcliffe T. W., Mulloy B., Johnson E. A., Thomas D. P.: The anticoagulant activity of heparin: measurement and relationship to chemical structure — J. pharmaceut. Biomed.7, 217, 1989.
3. Basu D., Gallus A., Hirsh J., Cade J.: A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time — New Engl. J. Med.287, 324, 1972.
4. Fennerty A., Campbell I. A.: Anticoagulants in venous thromboembolism. Guidelines for optimum treatment — Brit. med. J.297, 1285, 1988.
5. Gawoski J. M., Arkin C. F., Bovill T., Brandt J., Rock W. A., Triplett D. A.: The effects of heparin on the activated partial thromboplastin time of the College of American Pathologists survey specimens — Arch. Pathol. Lab. Med.111, 785, 1987.